PEPTINOV

📍 Paris, France🗓 Founded 2010👥 16 employees💰 Last funded Jun 2022
Biotechnology Research🌐 peptinov.fr
Website LinkedIn
Peptinov is a biotechonology company based in Cochin Hospital (Paris, France) and founded by Prof. Jean-François Zagury to develop innovative peptide-based immunotherapies to treat chronic inflammatory diseases. Peptinov’s strategy is to induce the production of antibodies targeting self-proteins directly by the organism of the patient, through immunizations against carefully selected, highly immunogenic peptide sequences. Peptinov’s high potential R&D platform uses the tools of bioinformatics and molecular modelling to design these peptide sequences. This platform is potentially applicable to any crystallized protein and can quickly generate peptide candidates. Peptinov’s value proposition is built on its unique capability to develop anti-self proteins products in the current pharmaceutical markets. Peptinovs most advanced product targets IL-6, a central pro-inflammatory cytokine involved in the pathogenesis of several diseases. Peptinovs anti-IL-6 immunotherapy is now in phase 1 clinical development. Video of Peptinovs approach: https://youtu.be/8j0GvgqPjxQ
3
Total investors
0
Early stage
0
Mid stage
2
Late stage
2010
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
3
Investor activity2016–2022 · investors recorded per year
201612018120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in PEPTINOV?
PEPTINOV has 3 investors on record on gritt.io and 2 late-stage investors.
When did PEPTINOV last raise funding?
The most recent investment in PEPTINOV recorded on gritt.io was in June 2022.
When was PEPTINOV founded?
PEPTINOV was founded in 2010.
What industry is PEPTINOV in?
PEPTINOV operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is PEPTINOV based?
PEPTINOV is headquartered in Paris, France.